天邁科技(300807.SZ):中標6296.989萬元的長春公交集團公交智能化建設一期工程
格隆匯12月9日丨天邁科技(300807.SZ)公佈,公司近期參與了長春公交集團公交智能化建設一期工程的投標,中國招標投標公共服務平台於2021年12月9日發佈了長春公交集團公交智能化建設一期工程中標結果公吿,公司為該項目的中標人,該項目的招標方式為公開招標。
此次項目中標總金額為6296.989萬元,約佔公司2020年度經審計營業收入的29.15%。該項目屬於公司的主營業務範圍,後續若能簽訂合同,將有利於擴大公司在智能公交領域的市場份額,並對公司的未來經營業績產生積極影響,該項目的履行不影響公司經營的獨立性。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.